These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37109593)

  • 1. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection.
    Melendo-Viu M; Dobarro D; Raposeiras Roubin S; Llamas Pernas C; Moliz Cordón C; Vazquez Lamas M; Piñón Esteban M; Varela Martínez MÁ; Abu Assi E; Pita Romero R; Legarra Calderón JJ; Íñiguez Romo A
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destination therapy with left ventricular assist devices: for whom and when?
    Porepa LF; Starling RC
    Can J Cardiol; 2014 Mar; 30(3):296-303. PubMed ID: 24565254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.
    Karason K; Lund LH; Dalén M; Björklund E; Grinnemo K; Braun O; Nilsson J; van der Wal H; Holm J; Hübbert L; Lindmark K; Szabo B; Holmberg E; Dellgren G;
    Eur J Heart Fail; 2020 Apr; 22(4):739-750. PubMed ID: 32100946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device as destination therapy for end stage heart failure: the right time for the right patients.
    Fukunaga N; Rao V
    Curr Opin Cardiol; 2018 Mar; 33(2):196-201. PubMed ID: 29319565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices.
    Arabía FA; Milano CA; Mahr C; McGee EC; Mokadam NA; Rame JE; Moriguchi JD; Ramzy D; Naftel DC; Myers SL; Kirklin JK
    Ann Thorac Surg; 2018 Feb; 105(2):548-555. PubMed ID: 29157741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation?
    Kirklin JK; Naftel DC; Pagani FD; Kormos RL; Stevenson L; Miller M; Young JB
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):584-603; discussion 597-8. PubMed ID: 22795459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Teuteberg JJ; Stewart GC; Jessup M; Kormos RL; Sun B; Frazier OH; Naftel DC; Stevenson LW
    JACC Heart Fail; 2013 Oct; 1(5):369-78. PubMed ID: 24621968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of primary biventricular support: an analysis of data from the EUROMACS registry.
    Vierecke J; Gahl B; de By TMMH; Antretter H; Beyersdorf F; Caliskan K; Krachak V; Loforte A; Potapov E; Schoenrath F; Stockman B; Vanderheyden M; Meyns B; Gummert J; Mohacsi P
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1037-1045. PubMed ID: 31369075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients on continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Naka Y
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1606-14. PubMed ID: 25260275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.
    McNamara N; Narroway H; Williams M; Brookes J; Farag J; Cistulli D; Bannon P; Marasco S; Potapov E; Loforte A
    Ann Cardiothorac Surg; 2021 Mar; 10(2):186-208. PubMed ID: 33842214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it Become a First Line Therapy?
    Bonacchi M; Harmelin G; Bugetti M; Sani G
    Front Surg; 2015; 2():35. PubMed ID: 26284251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.